ORA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ormat Technologies Inc (ORA) is currently not a strong buy for a beginner investor with a long-term focus. While the company has a solid position in the geothermal energy sector and a positive long-term outlook, the recent financial performance shows declining net income and EPS, which may indicate short-term challenges. Additionally, the stock's technical indicators and options data do not suggest a strong immediate upside. Given the investor's preference for long-term stability and the lack of strong buy signals, holding off on purchasing at this time is recommended.
The stock's MACD is positive and expanding, indicating bullish momentum. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the RSI is neutral at 58.305. Key support is at 106.025, and resistance is at 112.381. However, the stock has a 70% chance of declining in the next day (-3.36%) and week (-5.21%), suggesting short-term downside risk.
The company is a leader in geothermal energy, which is well-positioned for long-term growth due to increasing demand for clean, always-on power. Analysts have maintained positive ratings with price targets ranging from $108 to $148, indicating potential upside. The company also reported strong growth in storage revenue and margins.
Recent financials show a decline in net income (-23.19% YoY) and EPS (-23.88% YoY), along with a drop in gross margin (-10.41% YoY). Analysts have lowered price targets recently, citing slower-than-expected growth in the Electricity segment and muted margin recovery. Additionally, there is no recent news or significant insider/hedge fund activity to support immediate momentum.
In Q4 2025, revenue increased by 19.63% YoY to $276.04M, driven by strength in the Product and Storage segments. However, net income dropped by 23.19% YoY to $31.35M, and EPS fell by 23.88% YoY to $0.51. Gross margin also declined to 28.56%, down 10.41% YoY, reflecting challenges in the Electricity segment.
Analysts have a mixed but generally positive outlook on ORA. RBC Capital initiated coverage with an Outperform rating and a $130 price target. UBS and Barclays also maintain Buy ratings with price targets of $143 and $123, respectively. However, some firms, like JPMorgan and Jefferies, have expressed concerns about valuation and slower growth, resulting in Neutral or Hold ratings.
